Effect of Astaxanthin Phytochemical, Vitamin D3, Omega-3 and Vitamin E supplement on severity of mild to moderate COVID-19 Symptoms

Phase 3

Recruiting

• Conditions: Covid-19.; COVID-19, virus identified; U07.1

• Registration Number: IRCT20140804018677N9
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 June 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Positive test for COVID-19 according to WHO criteria and diagnosed with COVID-19 of mild to moderate severity
Willingness to participate in the project
age>18 years

Exclusion Criteria

Diagnosed with severe COVID-19 according to WHO criteria
Pregnancy
Using Omega-3 and/or vitamin E in 2 months before study initiation
Vitamin D deficiency
PN or EN need
Need for ICU admission

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Respiratory rate. Timepoint: baseline and at the end of the study. Method of measurement: pulsoximeter.;Pulse rate. Timepoint: baseline and at the end of the study. Method of measurement: Wrist radial atrial pulse.;Interlukin-6. Timepoint: baseline and at the end of the study. Method of measurement: ELISA.;Tumor necrotising factor alpha. Timepoint: baseline and at the end of the study. Method of measurement: ELISA.